Morgan Stanley Maintains Overweight on Accenture, Lowers Price Target to $400
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst James Faucette has maintained an Overweight rating on Accenture (ACN) but has lowered the price target from $417 to $400.

March 22, 2024 | 4:20 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley maintains an Overweight rating on Accenture but lowers the price target from $417 to $400.
While the reduction in price target could suggest a slightly less optimistic outlook on Accenture's future stock performance, the maintenance of an Overweight rating indicates that Morgan Stanley still views Accenture positively. This mixed signal could lead to neutral short-term price movement as investors digest both the positive and slightly negative aspects of this update.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100